What is the difference between a patent licence and a patent assignment in India?

A patent licence gives another party the right to use the patented invention in specified ways - for a defined territory, period, and field of use - while the patent owner retains ownership of the patent. The licensee pays royalties for this right. A patent assignment is a complete transfer of ownership of the patent from the assignor to the assignee. After assignment, the assignee becomes the new patent owner with all the rights the original owner had. Assignments require formal recording at the Indian Patent Office by filing Form 16. Licences should also be registered to be enforceable against third parties who acquire an interest in the patent.

What royalty rates are typical for technology licensing in India?

Royalty rates for technology licences in India vary significantly by industry, the strength of the IP, and the commercial stage of the technology. Indicative ranges: pharmaceutical and biotech patents typically command royalties of 2% to 10% of net sales; hardware and electronics patents 1% to 5%; software and SaaS technology 3% to 8% of revenue; brand licences (trademark only) 1% to 5% of net sales; franchise arrangements typically 2% to 6% of gross revenue. These are indicative ranges - the specific rate in any transaction depends on the exclusivity, territory, duration, and the relative bargaining power of the parties.

Can an Indian startup license its patents to foreign companies?

Yes - Indian startups can license their patents to foreign companies. However, cross-border patent licensing involving royalty payments to India requires compliance with FEMA (Foreign Exchange Management Act) regulations. Royalty payments received from foreign licensees must be credited to the startup's Indian bank account and reported to the RBI as per the applicable reporting norms. The licence agreement should clearly specify the governing law (Indian law is recommended for the IP provisions), the dispute resolution mechanism (WIPO arbitration or ICC arbitration is commonly specified for international licences), the currency of payment, and the applicable withholding tax treatment in the licensee's jurisdiction.

What is a joint development agreement and when is it appropriate?

A joint development agreement (JDA) is a contract between two or more parties to collaborate on developing technology together, specifying in advance who will own the resulting IP. JDAs are appropriate when a startup is co-developing technology with a corporate partner, a research institution, or another startup where both parties are contributing resources and both parties expect to benefit from the resulting IP. The critical provisions in a JDA are: ownership of background IP (each party retains ownership of what they bring in); ownership of foreground IP (the new IP created in the collaboration - this can be joint, split by domain, or assigned to one party); licensing rights back to the other party; and what happens to the JDA IP if the partnership terminates.

Patent Commercialisation for Startups India 2026

The Gap Between Patent Filing and Patent Value

Obtaining a patent is only the first step in extracting value from an invention. A patent that is filed, granted, and then maintained without any commercialisation strategy generates costs - annual maintenance fees, professional fees for responses to office actions, renewal fees - but no revenue. For Indian startups operating with capital constraints, treating patents purely as defensive tools without a commercialisation plan is a significant missed opportunity.

This guide covers every route through which a startup can extract commercial value from its patent portfolio - from direct licensing to technology transfer, from patent assignments to IP-backed financing.

Patent Licensing — The Primary Commercialisation Route

Patent licensing is the most common way startups monetise patents without divesting them. A licence grants a third party the right to use the patented technology in specified ways, in exchange for royalty payments, an upfront licence fee, or both. Licensing allows the startup to retain ownership of the patent while generating revenue from others' commercial activities.

Licences can be structured in several ways. Exclusive licences grant rights to only one licensee in a defined territory and field - the licensor cannot grant the same rights to anyone else. Exclusive licences typically command higher royalties but limit the licensor's flexibility. Non-exclusive licences can be granted to multiple licensees simultaneously - common for technology that has broad applicability across industries. Sub-licensable licences allow the licensee to further license the technology to their own customers or partners.

Royalty Structures and Payment Mechanisms

The royalty structure in a patent licence agreement has significant commercial implications for both parties. Running royalties - a percentage of the licensee's net revenue from products incorporating the licensed technology - align the licensor's income with the licensee's commercial success. Upfront licence fees provide immediate cash but may be lower total value if the licensee achieves significant commercial scale. Milestone payments - triggered by specific events such as regulatory approval, first commercial sale, or achieving revenue thresholds - are common in pharmaceutical licensing where the development timeline and commercial success are uncertain.

For Indian startups licensing to Indian companies, the royalty percentage should reflect the value contribution of the patent to the licensed product. A patent covering the core enabling technology of a product justifies a higher royalty (5-10%) than a patent covering one feature among many (0.5-2%). Benchmarking against comparable licences in the industry - disclosed in public company filings and academic licensing databases - provides useful reference points.

Technology Transfer Agreements

Technology transfer goes beyond patent licensing to include the transfer of know-how, technical expertise, manufacturing processes, quality systems, and training - all the tacit knowledge that makes the patented invention commercially workable. Many high-value technologies require accompanying know-how for successful implementation, making a pure patent licence insufficient for the licensee's needs.

Technology transfer agreements should clearly delineate: what patents are being licensed; what technical documentation, know-how, and training are being provided; what ongoing technical support the licensor will provide; confidentiality obligations for the transferred know-how; and what happens to the know-how at the end of the agreement term. In India, outbound technology transfer involving export of technical knowledge requires compliance with applicable export control regulations and, in some sectors, regulatory approvals.

Patent Assignments — When to Sell Your Patent

Assigning a patent - selling it outright to another party - generates an immediate lump sum payment but permanently transfers all future rights. Assignment is appropriate when the startup is exiting a technology area, when the patent is in a field the startup no longer operates in, or when a corporate acquirer makes a compelling offer for the patent as a standalone asset.

The assignment price for a patent depends on the remaining term, the strength and breadth of the claims, the commercial market for the technology, and the existence of active licensing or litigation involving the patent. Patent brokers, who specialise in identifying buyers for patents and facilitating transactions, can be valuable intermediaries for startups seeking to monetise non-core patents through assignment.

University Collaborations and Research Commercialisation

Many Indian deep-tech startups emerge from or maintain relationships with IITs, IISc, CSIR laboratories, and other research institutions. These relationships create specific IP ownership questions that must be addressed through formal collaboration agreements. The National IPR Policy 2016 and the Office of Technology Transfer established at many central universities have created frameworks for licensing university-owned patents to startups, sometimes in exchange for equity stakes.

Startups licensing technology from universities should understand: who owns the background IP contributed by the university versus the startup; who files and maintains patents on jointly developed IP; what the royalty structure is for commercialisation; and whether the university has the right to revoke the licence if the startup fails to achieve commercial development milestones. The NRDC (National Research Development Corporation) also maintains a technology licensing programme that Indian startups can access for commercialising government-funded research.

IP-Backed Financing

A growing number of Indian financial institutions and NBFCs are developing IP-backed lending products that allow patent-owning startups to raise debt financing using their patent portfolio as collateral. While IP-backed lending is still less common in India than in the US and Europe, the RBI's framework for intangible asset valuation and SIDBI's IP-focused lending initiatives have created growing infrastructure for this type of financing. For startups with valuable granted patents and strong commercial revenues, IP-backed financing can provide non-dilutive capital as an alternative to equity funding.

Commercialisation Red Flag

Granting an exclusive licence to a corporate partner without including development milestones and a reversion clause. Exclusive licences can lock your technology away from the market if the exclusive licensee fails to develop or commercialise it. Always include minimum commercialisation obligations, annual reporting requirements, and a termination or reversion right if the licensee fails to meet them.

For the broader IP strategy context, read the IP Strategy for Startup Growth guide and explore the full repository at the Startup IP Hub.

Creating a Patent Commercialisation Roadmap

Every startup with patents should have a commercialisation roadmap that maps each patent to a specific commercial strategy. Core product patents - those covering the primary technology on which the business is built - are typically deployed defensively, preventing competitors from copying and supporting the startup's freedom to operate. Peripheral patents - covering improvements, alternative implementations, or adjacent applications - are candidates for licensing to non-competing businesses.

The roadmap should also identify patents in technology areas the startup no longer actively pursues. These patents often have value to other companies in those areas and can be licensed or assigned to generate revenue without affecting the startup's core operations. Building this commercialisation map requires input from both the technical and commercial teams - the technical team understands what each patent covers, while the commercial team understands where adjacent market opportunities exist. For the complete IP strategy framework, visit the IP Strategy guide and the Startup IP Hub.

Patent Commercialisation for Indian Startups — Licensing, Technology Transfer, Assignments, and Revenue Strategies